TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE

NCT01791842 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Fibrous Dysplasia of Bone

Interventions

DRUG: Tocilizumab
DRUG: Placebo

Sponsor

Hospices Civils de Lyon